JODI POWELL: Open Payments
NPI 1134245582 · BUSH, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 53 payments from 18 companies in 2025. Trend: 2023 $1,346 · 2024 $1,083 · 2025 $1,400
Food & beverage: $1,400
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $410 |
| ABBVIE INC. | 11 | $262 |
| GlaxoSmithKline, LLC. | 9 | $170 |
| Novo Nordisk Inc | 7 | $118 |
| PFIZER INC. | 5 | $96 |
| GENZYME CORPORATION | 1 | $73 |
| Lilly USA, LLC | 3 | $47 |
| Dexcom, Inc. | 2 | $43 |
| Saluda Medical Americas, Inc. | 1 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, SHINGRIX, DUPIXENT, TRELEGY ELLIPTA, CREON, Ozempic.
Industry payments across LA — which companies pay providers there.
